fda bpc-157 statement Big review coming this July. Here's what athletes and patients should know about BPC-157, TB-500, and the broader peptide conversation. Always speak with your physician before starting any new protocol. #bpc157 # BPC-157 Before the FDA: Briefing

Treatment isn't recommended for general wellness without documented need, as inappropriate use may mask other nutritional deficiencies or create imbalances

References 1 Journal of Pharmacological SciencesKlicek R et al

If cannabis is legal in your state, you cannot freely use it on government property

Peptide therapy may benefit those who experience: Difficulty falling asleep or staying asleep Frequent night wakings Fatigue despite 78 hours in bed Jet lag or shift work-related sleep disturbances Sleep disruption from anxiety or high stress Hormonal imbalances (low GH, testosterone, melatonin) Aging-related decline in sleep quality Lifestyle and Supplement Synergy Peptides work best when paired with foundational sleep-supporting practices: Maintain a consistent bedtime and wake time Limit blue light exposure after sunset Avoid stimulants in the afternoon Incorporate magnesium, L-theanine, and GABA supplements Use adaptogens like ashwagandha or rhodiola to reduce cortisol Safety, Dosing, and Clinical Considerations Peptide therapy should always be administered under the supervision of a qualified provider

Results: A total of 56 RCTs was included in the current network meta-analysis

They cover peptide basics, the preclinical evidence for BPC-157 and TB-500, mechanisms like angiogenesis and tissue repair, the lack of robust human trials, sourcing risks, regulatory bans, and the gap between anecdotal reports and scientific certainty